Low-molecular weight heparin as prophylaxis against thromboembolism after total hip replacement--is it worth the price?
Persson
B M
BM
D000925:Anticoagulants / Q000009:adverse effects* / Q000191:economics; D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects*; D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects* / Q000191:economics; D006801:Humans; D013548:Sweden / Q000453:epidemiology; D013923:Thromboembolism / Q000209:etiology* / Q000401:mortality / Q000517:prevention & control*; D016896:Treatment Outcome
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight